/ 164 Shares
26-Aug-2025 - 29-Aug-2025
₹ 86 - ₹ 91
₹ 14924.00
164
13,300,000
Face Value - ₹ 10/- Per Share
Listing at BSE, NSE
8,109 Application Required in Retail for 1 Time.
Registrar : KFin Technologies Limited
| Category | % | Shares/Amount |
|---|---|---|
| QIB | 75% | 9,975,000 Shares RS.90.77 CR |
| HNI 1 | 5% | 665,000 Shares RS.6.05 CR @ 290 FORM 1X |
| HNI 2 | 10% | 1,330,000 Shares RS.12.10 CR @ 579 FORM 1X |
| Retail | 10% | 1,330,000 Shares RS.12.10 CR @ 8110 FORM 1X |
| Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
|---|---|---|
| 8110 FORM 1X | 290 FORM 1X | 579 FORM 1X |
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Upto 2 Lakh) | 1 | 164 | ₹ 14,924 |
| Retail (Upto 2 Lakh) | 13 | 2132 | ₹ 194,012 |
| S-HNI (2 Lakh to 10 Lakh) | 14 | 2296 | ₹ 208,936 |
| S-HNI (2 Lakh to 10 Lakh) | 67 | 10988 | ₹ 999,908 |
| B-HNI (Above 10 Lakh) | 68 | 11152 | ₹ 1,014,832 |
29-Aug-2025 17:08
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 3,990,000 ₹ 36.31 Cr. | 10,689,028 ₹ 97.27 Cr. | 2.68x |
| HNI (<10 LAKH) | 665,000 ₹ 6.05 Cr. | 11,101,488 ₹ 101.02 Cr. | 16.69x |
| HNI2 (>10 LAKH) | 1,330,000 ₹ 12.10 Cr. | 10,059,924 ₹ 91.55 Cr. | 7.56x |
| RETAIL | 1,330,000 ₹ 12.10 Cr. | 62,889,080 ₹ 572.29 Cr. | 47.29x |
| Total | 7,315,000 | 94,739,520 | 12.95x |
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 3,990,000 ₹ 36.31 Cr. | 10,689,028 ₹ 97.27 Cr. | 2.68x |
| HNI (<10 LAKH) | 665,000 ₹ 6.05 Cr. | 11,101,488 ₹ 101.02 Cr. | 16.69x |
| HNI2 (>10 LAKH) | 1,330,000 ₹ 12.10 Cr. | 10,059,924 ₹ 91.55 Cr. | 7.56x |
| RETAIL | 1,330,000 ₹ 12.10 Cr. | 62,889,080 ₹ 572.29 Cr. | 47.29x |
| Total | 7,315,000 | 94,739,520 | 12.95x |
*Excluding Anchor
Total No. of Application Approx : ~331606 (40.89 Appwise)
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).
The company manufactures high-purity pharmaceutical intermediates (for API production) and active pharmaceutical ingredients (used in formulations for medicines, nutraceuticals, personal care, and animal health products).
The company offers pharmaceutical intermediates, APIs for medicines, nutraceuticals, personal care, and veterinary products, all manufactured following Indian and international pharmacopeia standards like IP, BP, EP, JP, and USP.
In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.
The company has received Drug Master File (DMF) approval from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid APIs. The company has filed 21 DMFs with global authorities and is in the process of filing for Ketoprofen and Dexketoprofen Trometamol approvals.
The company’s portfolio includes 65 commercialized products, 28 at the pilot stage, and 49 in laboratory testing.
The company ensures product quality through rigorous testing, analysis, and process improvements. Supported by four labs, the 34-member team, including 24 science graduates, ensures products meet customer and industry standards.
Products:
As of January 31, 2025, the company had 105 employees (excluding trainees) and 8 contract workers.
Competitive Strengths:
| Period Ended | 31 Jan 2025 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 160.96 | 128 | 111.55 | 84.97 |
| Total Income | 77.37 | 66.69 | 113.12 | 57.54 |
| Profit After Tax | 11.96 | 9.66 | 5.82 | -0.11 |
| Net Worth | 71.86 | 21.03 | 7.37 | 1.55 |
| Reserves and Surplus | 32.01 | 5.03 | -4.63 | -10.24 |
| Total Borrowing | 62.39 | 74.56 | 66.39 | 60.32 |
| Amount in ? Crore | ||||
The Company Anlon Healthcare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (in Millions) |
|---|---|---|
| 1 | Funding capital expenditure requirements for Proposed Expansion | 3,071.95 |
| 2 | Full or part repayment and/or prepayment of certain outstanding secured borrowingssecured borrowing (term loan)availed by the Company | 500 |
| 3 | Funding the working capital requirements of the Company | 4,315 |
| 4 | General corporate purposes |
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.
How to Apply for IPOs on Easy Investing
Step 01 : Once you create your account, Login to your acount.
Step 02 : Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Step 03 : Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Step 04 : Enter your UPI ID and you will receive mandate on your UPI App.
Step 05 : Once you accept the mandate, Application is submitted successful.
